{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:49:16Z","timestamp":1790621356236,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1310,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1124\/jpet.121.000567","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T16:29:42Z","timestamp":1615912182000},"page":"417-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["AM833 Is a Novel Agonist of Calcitonin Family G Protein\u2013Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists"],"prefix":"10.1016","volume":"377","author":[{"given":"Madeleine M.","family":"Fletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Keov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin T.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Mennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Hick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-8221","authenticated-orcid":false,"given":"Sebastian G.B.","family":"Furness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine R.","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Wootten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8902-2473","authenticated-orcid":false,"given":"Patrick M.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000567_bib1","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00121.2014","article-title":"A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats","volume":"307","author":"Andreassen","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.121.000567_bib2","doi-asserted-by":"crossref","first-page":"e92042","DOI":"10.1371\/journal.pone.0092042","article-title":"Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias","volume":"9","author":"Andreassen","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000567_bib3","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2006-2003","article-title":"Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study","volume":"92","author":"Aronne","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.121.000567_bib4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/oby.2009.478","article-title":"Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial","volume":"18","author":"Aronne","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.121.000567_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1124\/jpet.121.000567_bib6","doi-asserted-by":"crossref","first-page":"R1798","DOI":"10.1152\/ajpregu.00386.2007","article-title":"Effects of intermittent intraperitoneal infusion of salmon calcitonin on food intake and adiposity in obese rats","volume":"293","author":"Chelikani","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.121.000567_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bcp.2017.12.016","article-title":"Characterization of signalling and regulation of common calcitonin receptor splice variants and polymorphisms","volume":"148","author":"Dal Maso","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1463-1326.2011.01425.x","article-title":"A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats","volume":"13","author":"Feigh","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.121.000567_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nchembio.545","article-title":"Retromer terminates the generation of cAMP by internalized PTH receptors","volume":"7","author":"Feinstein","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.121.000567_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nchembio.206","article-title":"Sustained cyclic AMP production by parathyroid hormone receptor endocytosis","volume":"5","author":"Ferrandon","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.121.000567_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2016.09.021","article-title":"Ligand-dependent modulation of g protein conformation alters drug efficacy","volume":"167","author":"Furness","year":"2016","journal-title":"Cell"},{"key":"10.1124\/jpet.121.000567_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","article-title":"Activity of pramlintide, rat and human amylin but not A\u03b21-42 at human amylin receptors","volume":"155","author":"Gingell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.121.000567_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acsptsci.9b00089","article-title":"Distinct patterns of internalization of different calcitonin gene-related peptide receptors","volume":"3","author":"Gingell","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.121.000567_bib14","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI116046","article-title":"Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line","volume":"90","author":"Gorn","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.121.000567_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1208\/s12249-013-9987-4","article-title":"Preparation and characterization of PEGylated amylin","volume":"14","author":"Guerreiro","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1124\/jpet.121.000567_bib16","doi-asserted-by":"crossref","first-page":"E821","DOI":"10.1152\/ajpendo.00514.2015","article-title":"KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight","volume":"310","author":"Gydesen","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.121.000567_bib17","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.1152\/ajpendo.00419.2016","article-title":"Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog","volume":"313","author":"Gydesen","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.121.000567_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bph.13723","article-title":"A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference","volume":"174","author":"Gydesen","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/pr.115.010629","article-title":"Amylin\u202f: pharmacology, physiology, and clinical potential","volume":"67","author":"Hay","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.121.000567_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/joe.0.1660213","article-title":"Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors","volume":"166","author":"Hilton","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.121.000567_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14779072.2015.1054810","article-title":"Liraglutide for Type 2 diabetes and obesity: a 2015 update","volume":"13","author":"Iepsen","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1124\/jpet.121.000567_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcp.2016.09.009","article-title":"Internalized Receptor for Glucose-dependent Insulinotropic Peptide stimulates adenylyl cyclase on early endosomes","volume":"120","author":"Ismail","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF00400683","article-title":"Effect of 14 days\u2019 subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM","volume":"39","author":"Kolterman","year":"1996","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.121.000567_bib25","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1039\/C4OB01208A","article-title":"Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism","volume":"12","author":"Kowalczyk","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1124\/jpet.121.000567_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0026-895X(25)09678-6","article-title":"Cloning and characterization of an abundant subtype of the human calcitonin receptor","volume":"46","author":"Kuestner","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.119.257576","article-title":"The dual amylin and calcitonin receptor agonist KBP-088 induces weight loss and improves insulin sensitivity superior to chronic amylin therapy","volume":"370","author":"Larsen","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000567_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/jpet.119.263392","article-title":"The calcitonin receptor plays a major role in glucose regulation as a function of dual amylin and calcitonin receptor agonist therapy","volume":"374","author":"Larsen","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000567_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/jpet.119.263400","article-title":"Dose frequency optimization of the dual amylin and calcitonin receptor agonist KBP-088: long-lasting improvement in food preference and body weight loss","volume":"373","author":"Larsen","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.000567_bib30","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000567_bib31","doi-asserted-by":"crossref","first-page":"R1475","DOI":"10.1152\/ajpregu.00703.2009","article-title":"The role of amylin in the control of energy homeostasis","volume":"298","author":"Lutz","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.121.000567_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0196-9781(99)00208-9","article-title":"Amylin receptors mediate the anorectic action of salmon calcitonin (sCT)","volume":"21","author":"Lutz","year":"2000","journal-title":"Peptides"},{"key":"10.1124\/jpet.121.000567_bib33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.121.000567_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight","volume":"34","author":"Mack","year":"2010","journal-title":"Int J Obes"},{"key":"10.1124\/jpet.121.000567_bib35","doi-asserted-by":"crossref","first-page":"617400","DOI":"10.3389\/fendo.2020.617400","article-title":"Amylin and calcitonin: potential therapeutic strategies to reduce body weight and liver fat","volume":"11","author":"Mathiesen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/jpet.121.000567_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1124\/jpet.121.000567_bib37","first-page":"129","article-title":"Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells","volume":"9","author":"Michelangeli","year":"1983","journal-title":"J Cyclic Nucleotide Protein Phosphor Res"},{"key":"10.1124\/jpet.121.000567_bib38","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1210\/en.2007-1735","article-title":"Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors","volume":"149","author":"Morfis","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.121.000567_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)15016-5","article-title":"The kinetics of competitive radioligand binding predicted by the law of mass action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib40","doi-asserted-by":"crossref","first-page":"12178","DOI":"10.1038\/ncomms12178","article-title":"Monitoring G protein-coupled receptor and \u03b2-arrestin trafficking in live cells using enhanced bystander BRET","volume":"7","author":"Namkung","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.121.000567_bib41","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","article-title":"TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome","volume":"16","author":"Olsen","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.121.000567_bib42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1177\/1060028013509233","article-title":"Salmon calcitonin use and associated cancer risk","volume":"47","author":"Overman","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1124\/jpet.121.000567_bib43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2012.02197.x","article-title":"Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant \u0394(1-47)hCT((a)) function","volume":"168","author":"Qi","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib44","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/oby.2009.184","article-title":"Enhanced weight loss with pramlintide\/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy","volume":"17","author":"Ravussin","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.121.000567_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrendo.2017.122","article-title":"Current pharmacotherapy for obesity","volume":"14","author":"Srivastava","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1124\/jpet.121.000567_bib46","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1002\/chem.201303303","article-title":"Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists","volume":"19","author":"Tomabechi","year":"2013","journal-title":"Chemistry"},{"key":"10.1124\/jpet.121.000567_bib47","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1124\/mol.106.024257","article-title":"A critical role for the short intracellular C terminus in receptor activity-modifying protein function","volume":"70","author":"Udawela","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib48","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1124\/mol.105.021915","article-title":"Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors","volume":"69","author":"Udawela","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.121.000567_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00198-015-3339-z","article-title":"Does salmon calcitonin cause cancer? A review and meta-analysis","volume":"27","author":"Wells","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1124\/jpet.121.000567_bib50","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight and obesity","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.121.000567_bib51","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s13300-020-00816-y","article-title":"Drug therapy in obesity: a review of current and emerging treatments","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1124\/jpet.121.000567_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev Res"},{"key":"10.1124\/jpet.121.000567_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bcpt.13427","article-title":"Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases","volume":"127","author":"Zakariassen","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/jpet.121.000567_bib54","doi-asserted-by":"crossref","first-page":"107987","DOI":"10.1016\/j.neuropharm.2020.107987","article-title":"Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice","volume":"167","author":"Zakariassen","year":"2020","journal-title":"Neuropharmacology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T16:54:36Z","timestamp":1740675276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022356524270324"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000567","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AM833 Is a Novel Agonist of Calcitonin Family G Protein\u2013Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The Author(s)","name":"copyright","label":"Copyright"}]}}